By Joe Flower Got a Safeway card?
It is also full of discussion, even heated arguments,
If you do, then the Safeway grocery store chain can
over who owns this valuable information. Whether infor-
know as much as it wants to know about whether you
mation gathered outside of medical channels, through
like Skyy vodka, whether you buy Pampers in the super
electronic scanning and cross-characterization of databases
family box, and whether you go for organic foods.
among retailers, distributors and manufacturers, becomes
subject to HIPAA restrictions is a regulatory question of
What about the pharmacy at Safeway? They know if
Talmudic complexity. But big money will be weighing in
you are taking birth control pills, or AIDS drugs or anti-
on the side of using the information commercially.
Imagine that distributors, device manufacturers and
No big deal? No big deal—your pharmacy has always
pharmaceutical companies gain direct, case-detailed
known this information, and besides, they are covered
access to your patients and potential patients. Imagine
by Health Insurance Portability and Accountability Act
that you run a respiratory clinic, or a sleep center.
(HIPPA). They can’t just sell that information, or trade it
Imagine your patients receiving e-mails or postcards,
individualized to their case, from someone else across
But let’s take another step here and see how new
town, saying that they can provide the service better,
technologies can shift power structures and business
faster or cheaper. Your crosstown rival received this infor-
mation from their suppliers—a pharmaceutical company,
We have had bar codes for 30 years. They carry
a device manufacturer, or a distributor—as part of a joint
UPCs—Universal Product Codes —that identify the prod-
uct. So every Safeway can know how many Diet Cokes
Does this seem farfetched? Health plans are already
and Foster Farms Frozen Chicken Thighs they have
up to their elbows in the massive job of restructuring
sold—and so can the distributors and manufacturers who
their entire business models around just such deep,
The new thing is RFIDs—radio frequency identification
Of course, health plans do not need to derive the
chips. They carry EPCs – Electronic Product Codes—that
fact that Mr. McNally has asthma. They just need to slice
identify not just a product, but whatever particular object
and dice that information. And they are exceptionally
you put them on, whether it is a truck, a pallet, a carton, or
eager to find ways to use that information to hold down
an individual item like, for instance, a bottle of pills.
costs. They express their eagerness in their investments:
RFIDs, with the suitable infrastructure of hardware
Aetna, for instance, is spending about $300 million per
and software, allows the industry to track individual items
year, and United has spent over $2 billion in the last
from manufacture right to end user. It will likely soon
three years on business intelligence infrastructure.
be possible for the distributor or manufacturer to know
If it is not already true, it soon will be true that the
not just that the Rite Aid at Fifth and Main sells 47 pack-
health plans know more about your business than you
ages of Ventolin per week, but that Mr. McNally refills his
do. Any hospital CEO worth her salt can tick off exactly
Ventolin prescription every 52 days, on average.
which doctors bring in the most business.
But every doctor incurs costs as well—sometimes huge
Business intelligence
costs as the hospital expands or acquires new equipment to meet the doctors’ needs—and few hospital executives could
The health care industry is full of articles, presentations
tell you which doctors bring in the most profit.
and research papers about how useful this information will
Hospital charges are clear enough, but they are most-
be, how it will streamline distribution, lower costs, and
ly based on air and hand-waving—most hospitals could
keep down tampering, diversion and counterfeiting.
not really tell you what the average cholecystectomy costs
54 SEPTEMBER • OCTOBER 2006 THE PHYSICIANEXECUTIVE
THE PHYSICIANEXECUTIVE SEPTEMBER • OCTOBER 2006 55 The health care world is increasingly being driven by information—not data as mass quantities, but data deeply processed to extract mass customized meaning. And in this world, the providers are information-poor. Joe Flower is a nationally known building the new online world for health care executives, the Healthcare
Futures Exchange. He can be reached 54 SEPTEMBER • OCTOBER 2006 THE PHYSICIANEXECUTIVE
THE PHYSICIANEXECUTIVE SEPTEMBER • OCTOBER 2006 55
1. SYNOPSIS Name of Company: Name of Finished Product: Name of Active Ingredient: Title of the Study: A double-blind, randomised, parallel group study to compare the efficacy, safety, and tolerability of OxyContin taken in combination with gabapentin, versus placebo with gabapentin, for the treatment of moderate to severe neuropathic pain in patients with diabetes mellitus.